Cargando…
Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder
SUMMARY: A 53-year-old man who used growth hormone (GH), anabolic steroids and testosterone (T) for over 20 years presented with severe constipation and hypercalcaemia. He had benign prostatic hyperplasia and renal stones but no significant family history. Investigations showed – (1) corrected calci...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354728/ https://www.ncbi.nlm.nih.gov/pubmed/32698126 http://dx.doi.org/10.1530/EDM-20-0032 |
_version_ | 1783558150674186240 |
---|---|
author | Ravindran, Ravikumar Witczak, Justyna Bahl, Suhani Premawardhana, Lakdasa D K E Adlan, Mohamed |
author_facet | Ravindran, Ravikumar Witczak, Justyna Bahl, Suhani Premawardhana, Lakdasa D K E Adlan, Mohamed |
author_sort | Ravindran, Ravikumar |
collection | PubMed |
description | SUMMARY: A 53-year-old man who used growth hormone (GH), anabolic steroids and testosterone (T) for over 20 years presented with severe constipation and hypercalcaemia. He had benign prostatic hyperplasia and renal stones but no significant family history. Investigations showed – (1) corrected calcium (reference range) 3.66 mmol/L (2.2–2.6), phosphate 1.39 mmol/L (0.80–1.50), and PTH 2 pmol/L (1.6–7.2); (2) urea 21.9 mmol/L (2.5–7.8), creatinine 319 mmol/L (58–110), eGFR 18 mL/min (>90), and urine analysis (protein 4+, glucose 4+, red cells 2+); (3) creatine kinase 7952 U/L (40–320), positive anti Jo-1, and Ro-52 antibodies; (4) vitamin D 46 nmol/L (30–50), vitamin D3 29 pmol/L (55–139), vitamin A 4.65 mmol/L (1.10–2.60), and normal protein electrophoresis; (5) normal CT thorax, abdomen and pelvis and MRI of muscles showed ‘inflammation’, myositis and calcification; (6) biopsy of thigh muscles showed active myositis, chronic myopathic changes and mineral deposition and of the kidneys showed positive CD3 and CD45, focal segmental glomerulosclerosis and hypercalcaemic tubular changes; and (7) echocardiography showed left ventricular hypertrophy (likely medications and myositis contributing), aortic stenosis and an ejection fraction of 44%, and MRI confirmed these with possible right coronary artery disease. Hypercalcaemia was possibly multifactorial – (1) calcium release following myositis, rhabdomyolysis and acute kidney injury; (2) possible primary hyperparathyroidism (a low but detectable PTH); and (3) hypervitaminosis A. He was hydrated and given pamidronate, mycophenolate and prednisolone. Following initial biochemical and clinical improvement, he had multiple subsequent admissions for hypercalcaemia and renal deterioration. He continued taking GH and T despite counselling but died suddenly of a myocardial infarction. LEARNING POINTS: The differential diagnosis of hypercalcaemia is sometimes a challenge. Diagnosis may require multidisciplinary expertise and multiple and invasive investigations. There may be several disparate causes for hypercalcaemia, although one usually predominates. Maintaining ‘body image’ even with the use of harmful drugs may be an overpowering emotion despite counselling about their dangers. |
format | Online Article Text |
id | pubmed-7354728 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-73547282020-07-15 Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder Ravindran, Ravikumar Witczak, Justyna Bahl, Suhani Premawardhana, Lakdasa D K E Adlan, Mohamed Endocrinol Diabetes Metab Case Rep Unique/Unexpected Symptoms or Presentations of a Disease SUMMARY: A 53-year-old man who used growth hormone (GH), anabolic steroids and testosterone (T) for over 20 years presented with severe constipation and hypercalcaemia. He had benign prostatic hyperplasia and renal stones but no significant family history. Investigations showed – (1) corrected calcium (reference range) 3.66 mmol/L (2.2–2.6), phosphate 1.39 mmol/L (0.80–1.50), and PTH 2 pmol/L (1.6–7.2); (2) urea 21.9 mmol/L (2.5–7.8), creatinine 319 mmol/L (58–110), eGFR 18 mL/min (>90), and urine analysis (protein 4+, glucose 4+, red cells 2+); (3) creatine kinase 7952 U/L (40–320), positive anti Jo-1, and Ro-52 antibodies; (4) vitamin D 46 nmol/L (30–50), vitamin D3 29 pmol/L (55–139), vitamin A 4.65 mmol/L (1.10–2.60), and normal protein electrophoresis; (5) normal CT thorax, abdomen and pelvis and MRI of muscles showed ‘inflammation’, myositis and calcification; (6) biopsy of thigh muscles showed active myositis, chronic myopathic changes and mineral deposition and of the kidneys showed positive CD3 and CD45, focal segmental glomerulosclerosis and hypercalcaemic tubular changes; and (7) echocardiography showed left ventricular hypertrophy (likely medications and myositis contributing), aortic stenosis and an ejection fraction of 44%, and MRI confirmed these with possible right coronary artery disease. Hypercalcaemia was possibly multifactorial – (1) calcium release following myositis, rhabdomyolysis and acute kidney injury; (2) possible primary hyperparathyroidism (a low but detectable PTH); and (3) hypervitaminosis A. He was hydrated and given pamidronate, mycophenolate and prednisolone. Following initial biochemical and clinical improvement, he had multiple subsequent admissions for hypercalcaemia and renal deterioration. He continued taking GH and T despite counselling but died suddenly of a myocardial infarction. LEARNING POINTS: The differential diagnosis of hypercalcaemia is sometimes a challenge. Diagnosis may require multidisciplinary expertise and multiple and invasive investigations. There may be several disparate causes for hypercalcaemia, although one usually predominates. Maintaining ‘body image’ even with the use of harmful drugs may be an overpowering emotion despite counselling about their dangers. Bioscientifica Ltd 2020-07-05 /pmc/articles/PMC7354728/ /pubmed/32698126 http://dx.doi.org/10.1530/EDM-20-0032 Text en © 2020 The authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (http://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Unique/Unexpected Symptoms or Presentations of a Disease Ravindran, Ravikumar Witczak, Justyna Bahl, Suhani Premawardhana, Lakdasa D K E Adlan, Mohamed Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder |
title | Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder |
title_full | Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder |
title_fullStr | Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder |
title_full_unstemmed | Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder |
title_short | Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder |
title_sort | myositis, rhabdomyolysis and severe hypercalcaemia in a body builder |
topic | Unique/Unexpected Symptoms or Presentations of a Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354728/ https://www.ncbi.nlm.nih.gov/pubmed/32698126 http://dx.doi.org/10.1530/EDM-20-0032 |
work_keys_str_mv | AT ravindranravikumar myositisrhabdomyolysisandseverehypercalcaemiainabodybuilder AT witczakjustyna myositisrhabdomyolysisandseverehypercalcaemiainabodybuilder AT bahlsuhani myositisrhabdomyolysisandseverehypercalcaemiainabodybuilder AT premawardhanalakdasadke myositisrhabdomyolysisandseverehypercalcaemiainabodybuilder AT adlanmohamed myositisrhabdomyolysisandseverehypercalcaemiainabodybuilder |